Claris raises $57M in Series A as it awaits key trial readout on eye drug
Claris announced a $57 million Series A on Thursday morning as it launched from stealth. The Jersey City biotech is working …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.